AnPac Bio-Medical Science is Laboratory Services (Healthcare) in China that focus on Science Co Ltd business. Founded in 2010. They cover business area such as AnPac Bio-Medical Science Co Ltd, early cancer screening, detection, its innovative patented CDA technology, its proprietary CDA device, addition, its CDA technology, physician, cancer diagnosis, prognosis, recurrence.
Laboratory Services (Healthcare)
2010
( 14 years old in 2024 )
Science Co Ltd
-
No.801
Bixing Street, Bihu Town, Liandu District
Lishui, Zhejiang
China
Private
AnPac Bio-Medical Science Co Ltdearly cancer screeningdetectionits innovative patented CDA technologyits proprietary CDA deviceadditionits CDA technologyphysiciancancer diagnosisprognosisrecurrence
* We use standard office opening hours in near AnPac Bio-Medical Science's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
AnPac Bio-Medical Science is Laboratory Services (Healthcare) business from China that founded in 2010 (14 years old in 2024), AnPac Bio-Medical Science business is focusing on Science Co Ltd.
AnPac Bio-Medical Science headquarter office and corporate office address is located in No.801 Bixing Street, Bihu Town, Liandu District Lishui, Zhejiang China.
AnPac Bio-Medical Science was founded in China.
In 2024, AnPac Bio-Medical Science is currently focus on Science Co Ltd sector.
Above is snippet of Google Trends for "Science Co Ltd" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with AnPac Bio-Medical Science, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
